|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
CBAY | McWherter Charles | President of R&D | Sep 18 | Option Exercise | 5.00 | 21,746 | 108,730 | 36,746 | Sep 19 05:27 PM |
CBAY | McWherter Charles | President of R&D | Sep 18 | Sale | 16.22 | 21,746 | 352,733 | 15,000 | Sep 19 05:27 PM |
CBAY | McWherter Charles | President of R&D | Aug 18 | Option Exercise | 5.00 | 21,746 | 108,730 | 36,746 | Aug 18 07:03 PM |
CBAY | McWherter Charles | President of R&D | Aug 18 | Sale | 11.47 | 21,746 | 249,359 | 15,000 | Aug 18 07:03 PM |
CBAY | McWherter Charles | President of R&D | Jul 18 | Option Exercise | 5.00 | 21,749 | 108,745 | 36,749 | Jul 19 06:05 PM |
CBAY | McWherter Charles | President of R&D | Jul 18 | Sale | 11.43 | 21,749 | 248,519 | 15,000 | Jul 19 06:05 PM |
CBAY | McWherter Charles | President of R&D | Jun 20 | Option Exercise | 5.00 | 21,749 | 108,745 | 36,749 | Jun 21 06:46 PM |
CBAY | McWherter Charles | President of R&D | Jun 20 | Sale | 8.16 | 21,749 | 177,383 | 15,000 | Jun 21 06:46 PM |
CBAY | McWherter Charles | President of R&D | May 18 | Option Exercise | 5.00 | 21,749 | 108,745 | 36,749 | May 19 06:00 PM |
CBAY | McWherter Charles | President of R&D | May 18 | Sale | 9.08 | 21,749 | 197,387 | 15,000 | May 19 06:00 PM |
CBAY | McWherter Charles | SVP & Chief Scientific Officer | Nov 02 | Buy | 8.67 | 5,000 | 43,341 | 15,000 | Nov 06 08:43 PM |
CBAY | McWherter Charles | SVP & Chief Scientific Officer | Jul 20 | Buy | 7.43 | 5,000 | 37,137 | 10,000 | Jul 24 06:19 AM |
CBAY | McWherter Charles | Sr. Vice President | Apr 15 | Buy | 1.68 | 3,000 | 5,040 | 5,000 | Apr 19 07:54 AM |
CBAY | McWherter Charles | Sr. Vice President | May 15 | Buy | 3.16 | 2,000 | 6,318 | 2,000 | May 19 07:46 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite